Back
The Eastern Vs. Aligos Therapeutics Industry Stock Comparison
Sell
42
EML
The Eastern
Last Price:
$28.16
Seasonality Move:
8.8%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$40.60
Seasonality Move:
7.18%
Sell
42
The Eastern (EML)
is a Sell
Is The Eastern a Buy, Sell or Hold?
-
The current The Eastern [EML] share price is $27.99. The Score for EML is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
EML is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $38.35. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EML Stock Price Chart
What is The Eastern's stock price today?
-
The The Eastern share price today is $27.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EML is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $38.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
EML Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 42.65 | Sell |
Chaikin Money Flow: | -17067 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.99 - 29.63) | Sell |
Bollinger Bands (100): | (28.37 - 31.85) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.1 | Buy |
Relative Strength Index (14 RSI): | 79.33 | Buy |
Chaikin Money Flow: | 265554 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.3 - 32.5) | Buy |
Bollinger Bands (100): | (7.16 - 22.66) | Buy |
EML Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.23 | Sell |
20-day SMA: | 29.07 | Sell |
50-day SMA: | 30.01 | Sell |
200-day SMA: | 29.49 | Sell |
8-day EMA: | 29.11 | Sell |
20-day EMA: | 29.16 | Sell |
50-day EMA: | 29.57 | Sell |
200-day EMA: | 28.46 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34 | Buy |
20-day SMA: | 28.23 | Buy |
50-day SMA: | 17.95 | Buy |
200-day SMA: | 16.14 | Buy |
8-day EMA: | 33.62 | Buy |
20-day EMA: | 28.8 | Buy |
50-day EMA: | 21.66 | Buy |
200-day EMA: | 17.2 | Buy |
The Eastern Earnings Growth & EML Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
The Eastern Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |